title: Venture financing for mRNA-based vaccines declines 82% in 2025 YTD
source: Yahoo
date: 2025-10-07
url: https://finnhub.io/api/news?id=aae9b6d6445a31bed6a4f562bd683198b440127972198066877d62432c14d0e5
Venture financing for companies developing innovator mRNA-based drugs more than halved from $1.1m in 2023 to $488m in 2024.
